Piccha basti and concentrated kutaja kashmari capsule given to treat adenomyosis and fibroid uterus in females

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF PICCHA BASTI AND CONCENTRATED KUTAJA KASHMARI CAPSULE IN ABNORMAL UTERINE BLEEDING W.S.R TO ADENOMYOSIS AND FIBROID UTERUS - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079805

Enrollment

Registered

2025-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Fibroids size less than 8cms Subjects aged between 18 to 55 years

Exclusion criteria

Exclusion criteria: a)Post menopausal bleeding and patients with traumatic lesion of genital tract. b)Subjects suffering from any systemic disorders like Diabetes mellitus, Hypertension etc. c)Subjects with other cause of Abnormal uterine bleeding such as polyp, malignancy, coagulopathy, ovulatory dysfunction d)Anemia in which HB% is less than 6.5gm%.

Design outcomes

Primary

Measure	Time frame
Improvement in FIGO classification of uterine bleeding. Improvement in pictorial blood loss assessment chart. Improvement in TVUSG parametersTimepoint: Follow up on 30th day and after 60th day. DURATION OF STUDY: 60 days	—

Secondary

Measure	Time frame
To obtain an effective medical management in abnormal uterine bleeding. Reduction in the risk of anaemia and related complications Decrease in the incidence of Hysterectomy and other Surgical InterventionsTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Mamatha K V

Sri Dharmasthala Manjunatheshwara College of Ayurveda Hospital and Research centre Kuthpady Udupi Karnataka India 574118

mamath2@gmail.com9448215605

Outcome results